Methylfolate vs Folic Acid: Which Is Better When Trying to Conceive?

Methylfolate vs Folic Acid: Which Is Better When Trying to Conceive?

Folate (Vitamin B9) is one of the most important nutrients to consider when preparing for pregnancy. It supports normal DNA synthesis, cell division, red blood cell formation and maternal tissue growth during pregnancy—all processes that are especially important during the earliest stages of fetal development.

However, not all sources of vitamin B9 are identical.

Most conventional prenatal supplements contain folic acid, while some more advanced formulations use methylfolate, also known as L-methylfolate or 5-MTHF.

Both can contribute to healthy folate levels, but methylfolate is already in a biologically active form. This means it can enter the body’s folate pathway without first undergoing the same conversion steps required by folic acid.

So, what does that difference actually mean when you are trying to conceive?

What Is Folate and Why Is It Important?

Folate is the general name for vitamin B9 and the different forms in which it exists.

It is naturally present in foods including leafy green vegetables, beans, lentils, broccoli, asparagus, citrus fruits and avocado. However, it can be difficult to obtain sufficient amounts from food alone, particularly during the preconception and pregnancy period.

Folate is required for the creation of DNA and RNA, normal cell division and the production of healthy red blood cells. It also contributes to normal maternal tissue growth during pregnancy.

Adequate folate intake before conception is especially important because the neural tube, which later develops into the baby’s brain and spinal cord, forms during the first few weeks of pregnancy—often before someone knows they are pregnant.

What Is Folic Acid?

Folic acid is the synthetic form of vitamin B9 traditionally used in supplements and fortified foods.

It is stable, inexpensive and extensively researched. Most importantly, folic acid supplementation before conception and during early pregnancy has been directly shown to reduce the risk of neural tube defects.

For this reason, the NHS currently recommends taking 400 micrograms of folic acid every day, ideally beginning around three months before conception and continuing throughout the first 12 weeks of pregnancy. Some people with additional risk factors may instead be prescribed 5 mg by their doctor.

Folic acid is effective, but it is not immediately available to the body in its final active form.

After absorption, it must first be reduced by an enzyme called dihydrofolate reductase before entering the folate cycle. It must then pass through further metabolic stages before the body produces 5-MTHF—the main form of folate found in the bloodstream.

What Is Methylfolate?

Methylfolate—also known as L-methylfolate, 5-MTHF or 5-methyltetrahydrofolate—is the predominant form of folate circulating in human plasma.

Unlike folic acid, methylfolate has already undergone the metabolic steps required to reach this active form. It does not need to be reduced by dihydrofolate reductase or converted into 5-MTHF by the MTHFR enzyme.

This is not simply a marketing distinction.

5-MTHF plays a direct role in the conversion of homocysteine into methionine, which is then used to produce S-adenosylmethionine—an important methyl donor involved in numerous cellular processes.

Supplemental methylfolate has also been shown to have bioavailability equal to or greater than folic acid. The US National Institutes of Health notes that some individuals may benefit more from 5-MTHF supplementation, particularly where folate metabolism is affected by an MTHFR polymorphism.

Methylfolate vs Folic Acid: The Main Difference

The key difference is not that one provides vitamin B9 and the other does not. It is the stage at which each form enters the body’s folate pathway.

Folic acid

  • Must undergo several conversion stages

  • Requires activity from multiple enzymes

  • Has decades of direct evidence for preventing neural tube defects

  • Is widely used in standard prenatal supplements and fortified foods

  • Remains the form specifically recommended by current NHS guidance

Methylfolate

  • Is already in the principal folate form found in the bloodstream

  • Does not require the MTHFR conversion step

  • Has bioavailability equal to or greater than folic acid

  • Directly supplies the form needed for homocysteine remethylation

  • Does not result in circulating unmetabolised folic acid

  • Provides a practical active-form option regardless of MTHFR status

Methylfolate is therefore not simply a “premium” name for ordinary folate. It provides vitamin B9 at a later, more immediately usable stage of the metabolic pathway.

What Does the MTHFR Gene Have to Do With Folate?

The MTHFR gene provides instructions for producing an enzyme involved in converting folate into 5-MTHF.

Common variants include C677T and A1298C. Certain variants, particularly C677T, can reduce the activity of the MTHFR enzyme. This may result in lower production of biologically available 5-MTHF and can influence homocysteine levels, especially when overall folate intake is inadequate.

Methylfolate supplies the product that the MTHFR enzyme would ordinarily help create. In other words, it bypasses this particular metabolic stage entirely.

This gives methylfolate a genuine biological rationale for people who want a folate source that does not depend on their individual MTHFR enzyme activity.

However, having a common MTHFR variant does not mean that someone is completely unable to process folic acid. The CDC confirms that people with common MTHFR variants can still use folic acid and that 400 micrograms can raise blood folate levels regardless of genotype.

The more accurate conclusion is therefore not that folic acid “does not work” for people with MTHFR variants. It is that methylfolate removes the need for the MTHFR-dependent conversion step in the first place.

What About Unmetabolised Folic Acid?

The body has a limited capacity to reduce folic acid at one time. When that capacity is exceeded, a proportion may remain in the bloodstream as unmetabolised folic acid.

The health significance of unmetabolised folic acid is not yet fully understood, and its presence should not automatically be interpreted as harmful. However, methylfolate does not require the same reduction process and therefore does not produce unmetabolised folic acid in the same way.

In a randomised trial involving pregnant women, 5-MTHF maintained maternal blood folate concentrations as effectively as folic acid while resulting in lower concentrations of unmetabolised folic acid.

This provides another meaningful distinction between the two forms, even though further research is needed to determine whether it translates into different long-term pregnancy outcomes.

Is Methylfolate Better When Trying to Conceive?

Methylfolate offers several clear advantages as a supplemental form:

It is already biologically active, it bypasses the MTHFR conversion stage, it is highly bioavailable and it can maintain healthy folate status without producing unmetabolised folic acid.

Folic acid, meanwhile, has the longest history of use and the strongest direct clinical evidence for reducing neural tube defects. This is why public-health guidance continues to name folic acid specifically.

That does not make methylfolate an inferior or merely fashionable alternative. It means the two forms have different strengths:

Folic acid has the largest body of pregnancy outcome evidence, while methylfolate offers a more direct and metabolically advanced route to active folate.

Why CORE3 Uses L-Methylfolate

CORE3 was created for women who want a focused, high-dose preconception supplement without having to combine numerous separate products.

Each capsule provides 1,000 micrograms of L-methylfolate, supplied as calcium L-methylfolate.

We chose methylfolate deliberately because it:

  • Provides folate in an already active form

  • Bypasses the MTHFR-dependent conversion step

  • Has high bioavailability

  • Supports the folate and methylation pathways directly

  • Avoids the formation of unmetabolised folic acid

This decision was not based on claiming that folic acid is ineffective. It was based on selecting a form that can be used more directly and consistently, without depending on individual differences in the final conversion stage.

Alongside L-methylfolate, CORE3 provides:

  • 450 mg high-purity CoQ10

  • 4,000 IU vitamin D3

  • 1,000 micrograms L-methylfolate

  • Just one capsule per day

Rather than filling the formula with dozens of ingredients at minimal doses, CORE3 focuses on three carefully selected nutrients at meaningful amounts for the preconception period.

Discover CORE3 high-dose, one-capsule preconception support.

Can Methylfolate Replace Prescribed Folic Acid?

CORE3 is designed for use during the preconception period and should not be used to override individual medical advice.

Current UK recommendations specifically advise taking 400 micrograms of folic acid while trying to conceive and during the first 12 weeks of pregnancy.

Some people are prescribed 5 mg folic acid because of their medical history, medicines or a higher risk of neural tube defects. Methylfolate should not be assumed to replace a prescribed dose without discussing this with a doctor, pharmacist, midwife or fertility specialist.

The Bottom Line

Folic acid and methylfolate both provide vitamin B9, but they are processed differently.

Folic acid must pass through several metabolic stages before becoming active 5-MTHF. Methylfolate already provides the principal form of folate found in the bloodstream, bypassing the MTHFR conversion stage entirely.

That makes methylfolate more than a premium supplement trend. It is a highly bioavailable, biologically active and carefully considered form of an essential preconception nutrient.

This is why CORE3 uses 1,000 micrograms of L-methylfolate as part of its focused formula—bringing three important preconception nutrients together in just one daily capsule.

Explore the complete CORE3 formula and ingredient doses.

References

Centers for Disease Control and Prevention (2026) MTHFR Gene Variant and Folic Acid Facts.

Cochrane, K.M. et al. (2024) ‘Supplementation with (6S)-5-methyltetrahydrofolic acid appears as effective as folic acid in maintaining maternal folate status while reducing unmetabolised folic acid in maternal plasma’, British Journal of Nutrition, 131(1), pp. 92–102.

National Health Service (2026) Pregnancy Vitamins and Supplements.

National Institutes of Health, Office of Dietary Supplements (2022) Folate: Health Professional Fact Sheet.

Samaniego-Vaesken, M.L. et al. (2024) ‘Supplementation with folic acid or 5-methyltetrahydrofolate and prevention of neural tube defects: an evidence-based narrative review’, Nutrients, 16(18), 3154.

Back to blog